Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Siyoung A Lim1, Nathan Ho1, Sophia Chen1

  • 1Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.

Advanced Healthcare Materials
|April 27, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collecting Duct-Targeted Lipid Nanoparticles Deliver <i>Pkd2</i> mRNA to Restore Polycystin-2 and Attenuate ADPKD.

bioRxiv : the preprint server for biology·2026
Same author

Investigation of Urinary Extracellular Vesicles as Novel and Safe Therapeutics for Autosomal Recessive Polycystic Kidney Disease (ARPKD).

Journal of biomedical materials research. Part A·2026
Same author

The afterlife of 20 million AI chips.

Nature computational science·2025
Same author

Old but gold: ILC-induced T-cell senescence prevents GVHD.

Blood·2025
Same author

Bioengineering and nephrology converge to drive kidney-targeted therapies.

Nature reviews. Nephrology·2025
Same author

Leucine Zipper-based Cell Sorting for Purification of Dual-vector-transduced Cells.

Journal of visualized experiments : JoVE·2025
Same journal

Pathology-Targeted Nanoparticles Guided by Peptide Remodel the Periodontal Microenvironment for Periodontitis Therapy.

Advanced healthcare materials·2026
Same journal

Gellan Gum Fluid Gel System for Controlled-Delivery of Cytokine-Licensed MSC-EVs to Enhance Corneal Repair in Limbal Stem Cell Deficiency.

Advanced healthcare materials·2026
Same journal

Diabetic Wound Healing Enabled by a Tri-Functional MAX Phase via Cu Doping.

Advanced healthcare materials·2026
Same journal

Plasmonically Reinforced Self-Sufficient Nanozymes Dysregulating Redox Homeostasis for Augmented Cascade Catalytic Oncotherapy.

Advanced healthcare materials·2026
Same journal

Spontaneous Helical Alignment of Smooth Muscle Cells to Form a Medial Layer for Engineered Microvasculature.

Advanced healthcare materials·2026
Same journal

Injectable Antifouling Adhesive Hydrogel Enables Robust Neural Interfaces for Stable ECoG Recording.

Advanced healthcare materials·2026
See all related articles
This summary is machine-generated.

Natural killer cell-derived extracellular vesicles (NK-EVs) show potent anti-viral properties. These nanomaterials effectively reduce viral RNA and inflammation, offering a promising therapeutic alternative for viral infections.

Area of Science:

  • Immunology
  • Nanomedicine
  • Virology

Context:

  • Viral infections compromise host cells, prompting immune responses like Natural Killer (NK) cell activity.
  • NK cells combat viruses by inducing apoptosis and releasing cytokines.
  • Extracellular vesicles derived from NK cells (NK-EVs) possess inherent anti-viral capabilities due to their composition and cargo.

Purpose:

  • To characterize NK-EVs for their anti-viral potential.
  • To evaluate NK-EVs' size, protein expression, cellular uptake, biocompatibility, and miRNA cargo.
  • To assess NK-EVs' efficacy against viral RNA and pro-inflammatory markers in vitro and in vivo.

Summary:

  • NK-EVs were incubated with lung epithelial cells under conditions mimicking viral infections.
  • Treated cells showed upregulated anti-viral miRNAs (miR-27a, miR-27b, miR-369-3p, miR-491-5p) compared to controls.
Keywords:
COVID‐19SARS‐CoV‐2anti‐viralextracellular vesiclesnanoparticlesnatural killer cells

Related Experiment Videos

  • NK-EVs reduced viral RNA and pro-inflammatory cytokines (TNF-α, IL-8) in SARS-CoV-2 infected cells and mice without causing tissue damage.

    • Impact:

    • This study highlights NK-EVs as safe and effective anti-viral nanomaterials.
    • NK-EVs present a viable therapeutic platform, potentially replacing conventional NK cell and anti-viral treatments.
    • Demonstrates the potential of NK-EVs in managing viral infections and associated inflammation.